Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRMD | CORMEDIX INC | $12.50 | $12.15 | 2.92% | 48.08x | 13.44x | 9.88x | 7.38x | 0.42x | -$13.63M | -1.67% | $114.89M | 1.76 | $782.00M | 44.26 | ||
| CORT | CORCEPT THERAPEUTICS INC | $73.22 | $31.25 | 134.31% | 57.65x | 52.58x | 11.12x | 11.36x | 1.09x | $177.16M | 2.32% | $683.29M | 6.56 | $7.68B | 69.22 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.42 | $5.62 | 32.14% | 92.75x | 17.67x | 6.37x | 10.21x | 0.52x | -$8.51M | -1.32% | $68.12M | 0.79 | $682.22M | 51.08 | ||
| ARGX | ARGENX SE | $560.14 | $225.74 | 148.14% | 37.02x | 43.86x | 7,090.38x | 5.69x | 1.43x | -$91.90M | -0.27% | $5.98B | 99.85 | $32.45B | 283.83 | ||
| TGTX | TG THERAPEUTICS INC | $36.72 | $11.68 | 214.43% | 136.00x | 43.29x | 13.94x | 24.57x | 1.30x | -$61.10M | -1.14% | $237.29M | 1.62 | $5.95B | 84.48 | ||
| RPRX | ROYALTY PHARMA PLC | $35.87 | $48.41 | -25.91% | 14.52x | 7.95x | 6.90x | 2.06x | 0.37x | $2.58B | 16.49% | $9.79B | 22.48 | $26.70B | 19.94 | ||
| KRYS | KRYSTAL BIOTECH INC | $138.88 | $80.69 | 72.12% | 32.15x | 24.38x | 12.00x | 4.08x | 0.88x | $129.75M | 3.24% | $984.67M | 34.17 | $3.71B | 25.66 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $8.64 | $8.30 | 4.05% | 29.79x | 14.64x | 4.85x | 3.33x | 0.46x | $64.00M | 5.34% | $350.19M | 2.52 | $1.18B | 17.89 | ||
| VCEL | VERICEL CORP | $41.73 | $3.80 | 997.75% | 834.60x | 158.49x | 8.73x | 7.11x | 4.26x | -$6.61M | -0.32% | $295.49M | 5.92 | $2.12B | 126.09 | ||
| HALO | HALOZYME THERAPEUTICS INC | $52.21 | $43.29 | 20.62% | 13.56x | 10.11x | 5.93x | 13.34x | 0.87x | $495.76M | 7.71% | $482.27M | 3.91 | $7.76B | 11.02 | ||
| EXEL | EXELIXIS INC | $43.67 | $25.72 | 69.79% | 19.41x | 18.54x | 5.30x | 5.59x | 1.20x | $820.89M | 6.74% | $2.13B | 7.64 | $11.91B | 13.32 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $31.98 | $37.37 | -14.41% | 11.98x | 10.42x | 2.46x | 2.55x | 0.51x | $221.39M | 12.08% | $720.53M | 12.57 | $1.52B | 6.40 | ||
| MNKD | MANNKIND CORP | $3.76 | $2.00 | 87.76% | 37.60x | 20.51x | 3.83x | -19.50x | 0.94x | $21.82M | 1.91% | -$58.62M | -0.19 | $1.38B | 16.75 | ||
| INCY | INCYTE CORP | $68.37 | $22.08 | 209.70% | 235.76x | 14.38x | 3.00x | 3.61x | 1.20x | $302.71M | 2.29% | $3.67B | 18.93 | $11.33B | 27.84 | ||
| MDXG | MIMEDX GROUP INC | $5.94 | $5.00 | 18.90% | 22.00x | 22.85x | 2.48x | 4.33x | 0.61x | $64.60M | 7.39% | $202.78M | 1.38 | $789.58M | 12.47 | ||
| ADMA | ADMA BIOLOGICS INC | $18.16 | $9.16 | 98.34% | 20.64x | 29.77x | 9.40x | 11.61x | 1.55x | $90.64M | 2.10% | $373.42M | 1.57 | $4.34B | 26.97 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $21.78 | $19.19 | 13.49% | 13.20x | 10.07x | 4.95x | 3.34x | 0.79x | $267.57M | 10.11% | $794.28M | 6.54 | $2.08B | 7.01 | ||
| TECH | BIO-TECHNE CORP | $51.84 | $18.24 | 184.28% | 62.46x | 27.99x | 6.75x | 4.03x | 1.37x | $220.76M | 2.71% | $2.02B | 12.82 | $8.41B | 29.04 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $106.90 | $179.54 | -40.46% | 13.72x | 51.84x | 1.60x | 1.58x | 0.28x | $1.51B | 23.22% | $4.17B | 68.46 | $10.13B | 8.12 | ||
| VCYT | VERACYTE INC | $27.38 | $9.28 | 195.11% | 63.67x | 33.91x | 4.61x | 1.79x | 1.43x | $78.45M | 3.67% | $1.19B | 15.31 | $2.01B | 31.84 | ||
| NVO | NOVO NORDISK A S | $68.51 | $36.92 | 85.59% | 19.20x | 17.58x | 6.65x | 14.55x | 1.46x | $12.01B | 3.92% | $21.02B | 4.71 | $318.00B | 13.76 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.17 | $39.13 | 40.99% | 20.06x | 15.85x | 3.57x | 1.83x | 0.84x | $624.18M | 5.93% | $5.79B | 30.34 | $10.13B | 13.03 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $14.22 | $1.48 | 861.12% | 79.00x | 112.23x | 10.25x | 20.24x | 10.95x | $19.56M | 1.77% | $55.35M | 0.71 | $1.07B | 66.58 | ||
| GMAB | GENMAB A | $20.50 | $17.12 | 19.76% | 11.83x | 14.13x | 4.31x | 2.56x | 1.00x | $1.09B | 8.06% | $5.30B | 8.00 | $12.08B | N/A | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $22.12 | $8.08 | 173.87% | 16.03x | 44.76x | 3.70x | 4.84x | 25.71x | $148.44M | 4.02% | $765.24M | 4.59 | $3.52B | 12.66 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.